|
|
||||||||
PHYSIOLOGICAL REVIEWS Vol. 78 No. 4 October 1998,
pp. 1193-1231
Copyright ©1998 The American Physiological Society
Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, Canada; and Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin
Jones, Glenville, Stephen A. Strugnell, and Hector F. DeLuca. Current Understanding of the Molecular Actions of Vitamin D. Physiol. Rev. 78: 1193-1231, 1998.
The important reactions that occur to the vitamin D molecule and the important reactions involved in the expression of the final active form of vitamin D are reviewed in a critical manner. After an overview of the metabolism of vitamin D to its active form and to its metabolic degradation products, the molecular understanding of the 1
-hydroxylation reaction and the 24-hydroxylation reaction of the vitamin D hormone is presented. Furthermore, the role of vitamin D in maintenance of serum calcium is reviewed at the physiological level and at the molecular level whenever possible. Of particular importance is the regulation of the parathyroid gland by the vitamin D hormone. A third section describes the known molecular events involved in the action of 1
,25-dihydroxyvitamin D3 on its target cells. This includes reviewing what is now known concerning the overall mechanism of transcriptional regulation by vitamin D. It describes the vitamin D receptors that have been cloned and identified and describes the coactivators and retinoid X receptors required for the function of vitamin D in its genomic actions. The presence of receptor in previously uncharted target organs of vitamin D action has led to a study of the possible function of vitamin D in these organs. A good example of a new function described for 1
,25-dihydroxyvitamin D3 is that found in the parathyroid gland. This is also true for the role of vitamin D hormone in skin, the immune system, a possible role in the pancreas, i.e., in the islet cells, and a possible role in female reproduction. This review also raises the intriguing question of whether vitamin D plays an important role in embryonic development, since vitamin D deficiency does not prohibit development, nor does vitamin D receptor knockout. The final section reviews some interesting analogs of the vitamin D hormone and their possible uses. The review ends with possible ideas with regard to future directions of vitamin D drug design.
This article has been cited by other articles:
![]() |
J. H. White Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity Infect. Immun., September 1, 2008; 76(9): 3837 - 3843. [Full Text] [PDF] |
||||
![]() |
P. M Brannon, E. A Yetley, R. L Bailey, and M. F. Picciano Overview of the conference "Vitamin D and Health in the 21st Century: an Update" Am. J. Clinical Nutrition, August 1, 2008; 88(2): 483S - 490S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jones Pharmacokinetics of vitamin D toxicity Am. J. Clinical Nutrition, August 1, 2008; 88(2): 582S - 586S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Menezes, R. T. Cheney, A. Husain, M. Tretiakova, G. Loewen, C. S. Johnson, V. Jayaprakash, K. B. Moysich, R. Salgia, and M. E. Reid Vitamin D Receptor Expression in Normal, Premalignant, and Malignant Human Lung Tissue Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1104 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S Bevelander, E. S L C Pinto, A. V M Canario, T. Spanings, and G. Flik CYP27A1 expression in gilthead sea bream (Sparus auratus, L.): effects of calcitriol and parathyroid hormone-related protein J. Endocrinol., March 1, 2008; 196(3): 625 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Priya, V P Jyotsna, N Gupta, S Chumber, C S Bal, A K Karak, A Seth, and A C Ammini Clinical and laboratory profile of primary hyperparathyroidism in India Postgrad. Med. J., January 1, 2008; 84(987): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Lin, L.-C. Hsieh, M.-W. Kuo, J. Yu, H.-H. Kuo, W.-L. Lo, R.-J. Lin, A. L. Yu, and W.-H. Li Human TRIM71 and Its Nematode Homologue Are Targets of let-7 MicroRNA and Its Zebrafish Orthologue Is Essential for Development Mol. Biol. Evol., November 1, 2007; 24(11): 2525 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Alpert and U. Shaikh The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems Biol Res Nurs, October 1, 2007; 9(2): 117 - 129. [Abstract] [PDF] |
||||
![]() |
R. Bailey, J. D. Cooper, L. Zeitels, D. J. Smyth, J. H.M. Yang, N. M. Walker, E. Hypponen, D. B. Dunger, E. Ramos-Lopez, K. Badenhoop, et al. Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes Diabetes, October 1, 2007; 56(10): 2616 - 2621. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Arnson, H. Amital, and Y. Shoenfeld Vitamin D and autoimmunity: new aetiological and therapeutic considerations Ann Rheum Dis, September 1, 2007; 66(9): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Meyer, L. A. Zella, R. D. Nerenz, and J. W. Pike Characterizing Early Events Associated with the Activation of Target Genes by 1,25-Dihydroxyvitamin D3 in Mouse Kidney and Intestine in Vivo J. Biol. Chem., August 3, 2007; 282(31): 22344 - 22352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, G. P. Sims, X. X. Chen, Y. Y. Gu, S. Chen, and P. E. Lipsky Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation J. Immunol., August 1, 2007; 179(3): 1634 - 1647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Prosser, M. Kaufmann, B. O'Leary, V. Byford, and G. Jones Single A326G mutation converts human CYP24A1 from 25-OH-D3-24-hydroxylase into -23-hydroxylase, generating 1{alpha},25-(OH)2D3-26,23-lactone PNAS, July 31, 2007; 104(31): 12673 - 12678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Agic, Hong Xu, C. Altgassen, F. Noack, M. M. Wolfler, K. Diedrich, M. Friedrich, R. N. Taylor, and D. Hornung Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1{alpha}-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers Reproductive Sciences, July 1, 2007; 14(5): 486 - 497. [Abstract] [PDF] |
||||
![]() |
S. Wu, S. Ren, L. Nguyen, J. S. Adams, and M. Hewison Splice Variants of the CYP27b1 Gene and the Regulation of 1,25-Dihydroxyvitamin D3 Production Endocrinology, July 1, 2007; 148(7): 3410 - 3418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Nehring, C. Zierold, and H. F. DeLuca Lithocholic acid can carry out in vivo functions of vitamin D PNAS, June 12, 2007; 104(24): 10006 - 10009. [Abstract] [Full Text] [PDF] |
||||
![]() |
E J Lock, R Ornsrud, L Aksnes, F A T Spanings, R Waagbo, and G Flik The vitamin D receptor and its ligand 1{alpha},25-dihydroxyvitamin D3 in Atlantic salmon (Salmo salar) J. Endocrinol., June 1, 2007; 193(3): 459 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Williams and H. F. DeLuca Characterization of intestinal phosphate absorption using a novel in vivo method Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1917 - E1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. I. Ellison, R. L. Eckert, and P. N. MacDonald Evidence for 1,25-Dihydroxyvitamin D3-independent Transactivation by the Vitamin D Receptor: UNCOUPLING THE RECEPTOR AND LIGAND IN KERATINOCYTES J. Biol. Chem., April 13, 2007; 282(15): 10953 - 10962. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-P. Li, X. Qi, R. Pramanik, N. M. Pohl, M. Loesch, and G. Chen Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity J. Biol. Chem., January 19, 2007; 282(3): 1544 - 1551. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Samander and A. Arnold Mutational Analysis of the Vitamin D Receptor Does Not Support Its Candidacy as a Tumor Suppressor Gene in Parathyroid Adenomas J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5019 - 5021. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, L. Nguyen, J. Chan, B. A. Innes, J. N. Bulmer, M. D. Kilby, and M. Hewison Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells Biol Reprod, December 1, 2006; 75(6): 816 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sundaram, M. J. Beckman, A. Bajwa, J. Wei, K. M. Smith, G. H. Posner, and D. A. Gewirtz QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells. Mol. Cancer Ther., November 1, 2006; 5(11): 2806 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Overbergh, K. Stoffels, M. Waer, A. Verstuyf, R. Bouillon, and C. Mathieu Immune Regulation of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-{gamma}-Mediated Induction J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3566 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kutuzova, S. Akhter, S. Christakos, J. Vanhooke, C. Kimmel-Jehan, and H. F. DeLuca Calbindin D9k knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level PNAS, August 15, 2006; 103(33): 12377 - 12381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, P. Hener, Z. Zhang, S. Kato, D. Metzger, and P. Chambon Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis PNAS, August 1, 2006; 103(31): 11736 - 11741. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vigano, D Lattuada, S Mangioni, L Ermellino, M Vignali, E Caporizzo, P Panina-Bordignon, M Besozzi, and A M Di Blasio Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J. Mol. Endocrinol., June 1, 2006; 36(3): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Prosser, Y. Guo, Z. Jia, and G. Jones Structural Motif-Based Homology Modeling of CYP27A1 and Site-Directed Mutational Analyses Affecting Vitamin D Hydroxylation Biophys. J., May 15, 2006; 90(10): 3389 - 3409. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zierold, J. A. Mings, and H. F. Deluca 19nor-1,25-Dihydroxyvitamin D2 Specifically Induces CYP3A9 in Rat Intestine More Strongly than 1,25-Dihydroxyvitamin D3 in Vivo and in Vitro Mol. Pharmacol., May 1, 2006; 69(5): 1740 - 1747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Blumberg, I. Tzameli, I. Astapova, F. S. Lam, J. S. Flier, and A. N. Hollenberg Complex Role of the Vitamin D Receptor and Its Ligand in Adipogenesis in 3T3-L1 Cells J. Biol. Chem., April 21, 2006; 281(16): 11205 - 11213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seoane and R. Perez-Fernandez The Vitamin D Receptor Represses Transcription of the Pituitary Transcription Factor Pit-1 Gene without Involvement of the Retinoid X Receptor Mol. Endocrinol., April 1, 2006; 20(4): 735 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuda and G. Jones Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol. Cancer Ther., April 1, 2006; 5(4): 797 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Brown, C. S. Ritter, J. C. Knutson, and S. A. Strugnell The vitamin D prodrugs 1{alpha}(OH)D2, 1{alpha}(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells Nephrol. Dial. Transplant., March 1, 2006; 21(3): 644 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Vanhooke, J. M. Prahl, C. Kimmel-Jehan, M. Mendelsohn, E. W. Danielson, K. D. Healy, and H. F. DeLuca CYP27B1 null mice with LacZreporter gene display no 25-hydroxyvitamin D3-1{alpha}-hydroxylase promoter activity in the skin PNAS, January 3, 2006; 103(1): 75 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Wang, L. E. Tavera-Mendoza, D. Laperriere, E. Libby, N. Burton MacLeod, Y. Nagai, V. Bourdeau, A. Konstorum, B. Lallemant, R. Zhang, et al. Large-Scale in Silico and Microarray-Based Identification of Direct 1,25-Dihydroxyvitamin D3 Target Genes Mol. Endocrinol., November 1, 2005; 19(11): 2685 - 2695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matilainen, M. Malinen, K. Saavalainen, and C. Carlberg Regulation of multiple insulin-like growth factor binding protein genes by 1{alpha},25-dihydroxyvitamin D3 Nucleic Acids Res., September 26, 2005; 33(17): 5521 - 5532. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Diesel, J. Radermacher, M. Bureik, R. Bernhardt, M. Seifert, J. Reichrath, U. Fischer, and E. Meese Vitamin D3 Metabolism in Human Glioblastoma Multiforme: Functionality of CYP27B1 Splice Variants, Metabolism of Calcidiol, and Effect of Calcitriol Clin. Cancer Res., August 1, 2005; 11(15): 5370 - 5380. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Rohde and H. F. DeLuca All-trans Retinoic Acid Antagonizes the Action of Calciferol and Its Active Metabolite, 1,25-Dihydroxycholecalciferol, in Rats J. Nutr., July 1, 2005; 135(7): 1647 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P Dwivedi, P. H Anderson, J. L Omdahl, H L. Grimes, H. A Morris, and B. K May Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells Endocr. Relat. Cancer, June 1, 2005; 12(2): 351 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.E. C. Nordin and A. G. Need The Relation Between Serum Calcidiol and Calcitriol IBMS BoneKEy, May 1, 2005; 2(5): 7 - 16. [Full Text] [PDF] |
||||
![]() |
J. G. J. Hoenderop and R. J. M. Bindels Is vitamin D indispensable for Ca2+ homeostasis: lessons from knockout mouse models? Nephrol. Dial. Transplant., May 1, 2005; 20(5): 864 - 867. [Full Text] [PDF] |
||||
![]() |
E. Fahy, S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill Jr., R. C. Murphy, C. R. H. Raetz, D. W. Russell, Y. Seyama, W. Shaw, et al. A comprehensive classification system for lipids J. Lipid Res., May 1, 2005; 46(5): 839 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Townsend, C. M. Banwell, M. Guy, K. W. Colston, J. L. Mansi, P. M. Stewart, M. J. Campbell, and M. Hewison Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue Clin. Cancer Res., May 1, 2005; 11(9): 3579 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kumagai, L.-Y. Shih, S. V. Hughes, J. C. Desmond, J. O'Kelly, M. Hewison, and H. P. Koeffler 19-Nor-1,25(OH)2D2 (a Novel, Noncalcemic Vitamin D Analogue), Combined with Arsenic Trioxide, Has Potent Antitumor Activity against Myeloid Leukemia Cancer Res., March 15, 2005; 65(6): 2488 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Hendrix, P H Anderson, J L Omdahl, B K May, and H A Morris Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1{alpha}-hydroxylase gene to physiological stimuli using a transgenic mouse model J. Mol. Endocrinol., February 1, 2005; 34(1): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuda, V. Byford, A. Arabian, Y. Sakai, M. B. Demay, R. St-Arnaud, and G. Jones Altered Pharmacokinetics of 1{alpha},25-Dihydroxyvitamin D3 and 25-Hydroxyvitamin D3 in the Blood and Tissues of the 25-Hydroxyvitamin D-24-Hydroxylase (Cyp24a1) Null Mouse Endocrinology, February 1, 2005; 146(2): 825 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. J. Hoenderop, B. Nilius, and R. J. M. Bindels Calcium Absorption Across Epithelia Physiol Rev, January 1, 2005; 85(1): 373 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F DeLuca Overview of general physiologic features and functions of vitamin D Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1689S - 1696S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Swamy, T. C. Chen, S. Peleg, P. Dhawan, S. Christakos, L. V. Stewart, N. L. Weigel, R. G. Mehta, M. F. Holick, and R. Ray Inhibition of Proliferation and Induction of Apoptosis by 25-Hydroxyvitamin D3-3{beta}-(2)-Bromoacetate, a Nontoxic and Vitamin D Receptor-Alkylating Analog of 25-Hydroxyvitamin D3 in Prostate Cancer Cells Clin. Cancer Res., December 1, 2004; 10(23): 8018 - 8027. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nejentsev, J. D. Cooper, L. Godfrey, J. M.M. Howson, H. Rance, S. Nutland, N. M. Walker, C. Guja, C. Ionescu-Tirgoviste, D. A. Savage, et al. Analysis of the Vitamin D Receptor Gene Sequence Variants in Type 1 Diabetes Diabetes, October 1, 2004; 53(10): 2709 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, H. Taylor, D. Zehnder, M. D. Kilby, J. N. Bulmer, F. Shah, J. S. Adams, and M. Hewison Increased Expression of 25-Hydroxyvitamin D-1{alpha}-Hydroxylase in Dysgerminomas: A Novel Form of Humoral Hypercalcemia of Malignancy Am. J. Pathol., September 1, 2004; 165(3): 807 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nejentsev, L. Godfrey, H. Snook, H. Rance, S. Nutland, N. M. Walker, A. C. Lam, C. Guja, C. Ionescu-Tirgoviste, D. E. Undlien, et al. Comparative high-resolution analysis of linkage disequilibrium and tag single nucleotide polymorphisms between populations in the vitamin D receptor gene Hum. Mol. Genet., August 1, 2004; 13(15): 1633 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spach, L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol Genomics, July 8, 2004; 18(2): 141 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison Vitamin D and Placental-Decidual Function Reproductive Sciences, July 1, 2004; 11(5): 263 - 271. [Abstract] [PDF] |
||||
![]() |
T. Yamasaki, S. Izumi, H. Ide, and Y. Ohyama Identification of a Novel Rat Microsomal Vitamin D3 25-Hydroxylase J. Biol. Chem., May 28, 2004; 279(22): 22848 - 22856. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi, J. Tang, R. Pramanik, R. M. Schultz, S. Shirasawa, T. Sasazuki, J. Han, and G. Chen p38 MAPK Activation Selectively Induces Cell Death in K-ras-mutated Human Colon Cancer Cells through Regulation of Vitamin D Receptor J. Biol. Chem., May 21, 2004; 279(21): 22138 - 22144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Cheng, M. A. Levine, N. H. Bell, D. J. Mangelsdorf, and D. W. Russell Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase PNAS, May 18, 2004; 101(20): 7711 - 7715. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Plum, J. M. Prahl, X. Ma, R. R. Sicinski, S. Gowlugari, M. Clagett-Dame, and H. F. DeLuca Biologically active noncalcemic analogs of 1{alpha},25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl PNAS, May 4, 2004; 101(18): 6900 - 6904. [Abstract] [Full Text] [PDF] |
||||
![]() |